Characterization of PSA at death in patients with metastatic castration-resistant prostate cancer.

被引：1
|
作者：
Bikkasani, Krishna
Qin, Qian
Lin, Justin
Galsky, Matt D.
Liaw, Bobby Chi-Hung
Oh, William K.
Tsao, Che-Kai
机构：
[1] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, Tisch Canc Inst, New York, NY 10029 USA
[2] CUNY, Sch Med, New York, NY 10031 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.184
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
184
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The use of PSA free-to-total ratio for the prediction of metastatic castration-resistant prostate cancer patients
    Yiu, Ting Wai
    Woon, Dixon
    Wettstein, Marian
    Goldberg, Hanan
    Herrera-Caceres, Jaime
    Shiakh, Hina
    Nason, Gregory
    Zlotta, Alexandre
    Diamantis, Eleftherios
    Bolton, Damien
    Fleshner, Neil
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 : 118 - 119
  • [22] Rucaparib in castration-resistant, metastatic prostate cancer
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2024, 55 (02) : 96 - 98
  • [23] Management of Metastatic Castration-Resistant Prostate Cancer
    Srinivas, Sandy
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (5.5): : 614 - 616
  • [24] Olaparib for Metastatic Castration-Resistant Prostate Cancer
    Mutetwa, Tinaye
    Foulkes, William D.
    Polak, Paz
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (09): : 890 - 890
  • [25] Treatment of metastatic, castration-resistant prostate cancer
    von Amsberg, G.
    Merseburger, A. S.
    UROLOGE, 2020, 59 (06): : 673 - 679
  • [26] Cabazitaxel in metastatic castration-resistant prostate cancer
    Yap, Timothy A.
    Pezaro, Carmel J.
    de Bono, Johann S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (09) : 1129 - 1136
  • [27] Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer
    Leibowitz-Amit, R.
    Templeton, A. J.
    Omlin, A.
    Pezaro, C.
    Atenafu, E. G.
    Keizman, D.
    Vera-Badillo, F.
    Seah, J. -A.
    Attard, G.
    Knox, J. J.
    Sridhar, S. S.
    Tannock, I. F.
    de Bono, J. S.
    Joshua, A. M.
    ANNALS OF ONCOLOGY, 2014, 25 (03) : 657 - 662
  • [28] Treatment of Metastatic Castration-resistant Prostate Cancer With Abiraterone and Enzalutamide Despite PSA Progression
    Becker, Daniel J.
    Iyengar, Arjun D.
    Punekar, Salman R.
    Ng, Jason
    Zaman, Anika
    Loeb, Stacy
    Becker, Kevin D.
    Makarov, Danil
    ANTICANCER RESEARCH, 2019, 39 (05) : 2467 - 2473
  • [29] Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials
    Michael J. Grayling
    Martina McMenamin
    Robert Chandler
    Rakesh Heer
    James M. S. Wason
    BMC Cancer, 22
  • [30] Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials
    Grayling, Michael J.
    McMenamin, Martina
    Chandler, Robert
    Heer, Rakesh
    Wason, James M. S.
    BMC CANCER, 2022, 22 (01)
12345